ArticleNature communications2026
Polar solvent strategy enables scalable synthesis of perovskite nanocrystal scintillators for fast X-ray imaging.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Materials to Medical Images: Translating Perovskite-Based X-Ray Detectors Toward Clinical Imaging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
The increasing demand for high-speed X-ray imaging requires scintillators with high light yield and fast response. Perovskite nanocrystals are promising candidates due to their distinctive optical properties and solution processability. However, the fabrication of thick X-ray films, which are several orders of magnitude thicker than conventional optoelectronic devices, leads to severe material waste and reduced light yield caused by strong spectral overlap and self-absorption. In addition, conventional synthesis methods often suffer from low reaction yields and uncontrolled exciton pathways. Here, we develop a low-temperature polar-solvent synthesis method that achieves a reaction yield of 162 mg mL
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.